Population pharmacokinetics of lenalidomide in patients with B‐cell malignancies-Reference-Cited by-同舟云学术

Population pharmacokinetics of lenalidomide in patients with B‐cell malignancies

Published:2019-02-27 Issue:5 Volume:85 Page:924-934
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Hughes Jim H.¹^ORCID,Phelps Mitch A.²³^ORCID,Upton Richard N.¹^ORCID,Reuter Stephanie E.⁴^ORCID,Gao Yue³,Byrd John C.²³⁵,Grever Michael R.²⁵,Hofmeister Craig C.²⁵^ORCID,Marcucci Guido²⁵,Blum William²⁵,Blum Kristie A.²⁵,Foster David J.R.¹^ORCID

Affiliation:

1. Australian Centre for Pharmacometrics, School of Pharmacy and Medical Sciences, Division of Health Sciences University of South Australia Australia

2. Comprehensive Cancer Center The Ohio State University Columbus OH USA

3. Division of Pharmaceutics, College of Pharmacy The Ohio State University Columbus OH USA

4. School of Pharmacy and Medical Sciences, Division of Health Sciences University of South Australia Australia

5. Division of Hematology, Department of Internal Medicine The Ohio State University Columbus OH USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13873

Reference49 articles.

1. Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

2. Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide

3. Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate T cells by inducing degradation of T cell repressors I karos and A iolos via modulation of the E 3 ubiquitin ligase complex CRL 4 CRBN

4. Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma

5. Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics of lenalidomide in Chinese patients with influence of genetic polymorphisms of ABCB1;Scientific Reports;2024-01-31

2. Population pharmacokinetics of lenalidomide in Chinese patients with influence of genetic polymorphisms of ABCB1;2023-10-17

3. Population Pharmacokinetic Model for Tramadol and O-desmethyltramadol in Older Patients;European Journal of Drug Metabolism and Pharmacokinetics;2022-02-15

4. Population pharmacokinetic model of subcutaneous fentanyl in older acute care patients;European Journal of Clinical Pharmacology;2021-04-03

5. Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma—A Unique Entity;American Journal of Clinical Pathology;2020-09-03